Trial Profile
Efficacy of maintenance therapy with adalimumab in ulcerative colitis achieving remission with tacrolimus
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Tacrolimus
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 18 Dec 2014 New trial record